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Abstract The expression of the contractile proteins, K-actin,
smooth muscle myosin heavy chain-1 (SM1) and calponin present
in smooth muscle cells (SMC) in the presence of oxidized low
density lipoproteins (oxLDL) was investigated in two different
cell cultures: the mouse smooth muscle cell line SVSC and rat
smooth muscle cells (RSMC). Exposure of the cells to 187 Wg
protein/ml oxLDL for 24 h reduced the expression of all three
contractile proteins in both cell cultures when compared to cells
incubated in the presence of native LDL. This investigation of the
response of SMC contractile proteins to oxLDL may provide
further insights into the mechanisms by which oxidatively
modified LDL is atherogenic and suggests that oxLDL may
contribute to the regulation of the expression of the genes
responsible for the synthesis of smooth muscle cell contractile
proteins.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
It is widely asserted that oxidized low density lipoproteins
(oxLDL) play a central role in the pathogenesis of atheroscle-
rosis : a disease characterized by lesions resulting from an
excessive, in£ammatory-¢broproliferative response to various
forms of insult to the endothelium and smooth muscle of the
artery wall, ultimately leading to vessel occlusion responsible
for heart attacks and strokes [1^3]. Oxidatively modi¢ed LDL
is present in atherosclerotic lesions [4] and is believed to be a
key event in the development of atherosclerosis, mainly due to
its enhanced uptake by macrophages [5] and its ability to alter
gene expression in arterial cells. In fact, oxLDL exerts multi-
ple cellular e¡ects in macrophages and endothelial cells that
enhance lesion progression. In vascular smooth muscle cells
(SMC), oxLDL has been shown to induce an array of re-
sponses, such as increased expression of intracellular antiox-
idant stress proteins, heme oxygenase-1 and macrophage
stress protein MSP23 [6], which act as a cytoprotective de-
fence against oxidative stress, and increased expression of
heat shock protein hsp70 [7], which a¡ords protection against
proteotoxic factors. In addition, mildly oxidized LDL has
been observed to evoke a sustained and intense calcium-de-
pendent retraction of vascular SMC [8] and stimulated cell
proliferation by activation of metabolic enzymes [9]. Oxida-
tion of LDL is also associated with the stimulation of collagen
production in SMC [10] and with the formation of several
substances which a¡ect the growth of SMC such as lysophos-
phatidylcholine which stimulates DNA synthesis [11]. Since it
has been observed that SMC acquire certain phenotypic fea-
tures during atheroma formation such as changes in the rela-
tive expression of actin isoforms [12], it was of interest to
address the question of whether oxLDL may induce changes
in the expression of SMC contractile proteins, particularly if
one considers that the development of atherosclerotic plaques
is characterized by the transition of the SMC phenotype from
a contractile to a synthetic one. In this study, we investigated
the e¡ect of oxLDL on the expression of K-actin, the most
abundant actin isoform in normal vascular SMC [13], of
smooth muscle myosin heavy chain-1 (SM1), of calponin, a
thin ¢lament protein involved in the regulation of actin-my-
osin interactions in SMC [14], and of non-muscle myosin in
two di¡erent cell cultures: the mouse smooth muscle cell line
SVSC and rat smooth muscle cells (RSMC).
2. Materials and methods
2.1. Cell culture and treatment with LDL
RSMC were isolated from Wistar rat aortas by enzymatic digestion
and propagated as described [15]. Passages from 10 to 14 of RSMC
were used for the experiments. SVSC cells were isolated and estab-
lished from aortas of transgenic mice harboring the SV40 large T-
antigen gene [16]. The SVSC and RSMC cells obtained were cultured
in medium 199 supplemented with 10% fetal bovine serum, 2.2 g/l
NaHCO3, 100 U/ml penicillin G and 100 Wg/ml streptomycin, in col-
lagen-coated plastic petri dishes (Corning) in an incubator at 33‡C for
the SVSC cells and at 37‡C for the RSMC cells in a humidi¢ed
atmosphere of 5% CO2. For the experiments, the cells were seeded
in six multiwell culture dishes at a density of 5U104 cells/well, and
grown for 3 days in these conditions. Twenty-four hours before LDL
incorporation, the medium was removed and replaced with serum-free
medium 199; SVSC cells were incubated at 39‡C while RSMC cells
were kept at 37‡C in a 5% CO2 atmosphere. Cells were then incubated
with native or oxidized LDL (187 Wg protein/ml) for 24 h at 39‡C and
37‡C for SVSC and RSMC cells, respectively. Exposure to LDL was
terminated by gently washing the cells three times with ice-cold Dul-
becco’s phosphate bu¡ered saline.
2.2. Western blot analysis
Cells were lysed in bu¡er (1% Triton X-100, 50 mM Tris, 1 mM
EDTA, 0.1 mM p-amidinophenylmethylsulfonyl £uoride (pAPMSF)).
Sample total protein content was determined according to Lowry et
al. [17] and equal amounts of protein concentration from each sample
were boiled in a mixture of 10 mM Tris, 20% glycerol, 1% SDS, 0.02%
bromophenol blue for 3 min. Proteins and molecular weight markers
were subjected to SDS-PAGE on either 3% or 12.5% polyacrylamide
gels, using the bu¡er solution composed of 25 mM Tris, 192 mM
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glycine, 0.1% SDS. Electrophoresed proteins were transferred onto a
nitrocellulose membrane using a semi-dry blotter AE-665 (Atto, Ja-
pan) and Western blotting solution composed of 0.1 M Tris, 0.2 M
glycine, 0.01% SDS, 20% methanol. The membranes were blocked in
PBS/0.1% Tween-20 (PBST) containing 5% skimmed milk for 30 min
at 25‡C. The protein blots were then incubated with a 1:1000 dilution
of either monoclonal anti-K smooth muscle actin antibody, anti-cal-
ponin antibody or anti-non-muscle myosin antibody or with a 1:20
dilution of anti-smooth muscle heavy chain-1 antibody (KM995) and
incubated at 37‡C for 30 min. After three washes with PBST, the
membranes were incubated for 1 h at room temperature with a
1:2000 dilution of a secondary antibody conjugated to horseradish
peroxidase used as the marker for the antigenically reacted proteins;
these were anti-mouse IgG, anti-rabbit IgG and anti-rat IgG. The
membranes were then washed ¢ve times in PBST and the immune
complex was detected by an enhanced chemiluminescent method
(ECL, Amersham). Densitometric analysis of the autoradiograms
was carried out using an CS-9000 dual wavelength £ying spot scan-
ning densitometer (Shimadzu, Japan).
2.3. Preparation of LDL
LDL (density 1.019^1.063 g/ml) was isolated from normal human
blood by ultracentrifugation in the presence of EDTA, followed by
overnight dialysis against PBS at 4‡C, as described previously [18].
After protein determination using the Lowry method, LDL (200 Wg
protein/ml) in PBS was oxidized by incubation with 5 WM
CuSO4W5H2O at 37‡C for 3 h. The reaction was stopped by addition
of 1 mM EDTA followed by overnight dialysis of oxLDL against PBS
at 4‡C. Oxidized LDL was then passed through a 0.22 Wm sterilized
Millipore ¢lter followed by protein determination of oxLDL. The
oxidation and purity of sterilized LDL was evaluated by electropho-
resis mobility on agarose gels and it was stored at 4‡C under N2 for
no longer than 2 weeks.
2.4. Materials
Medium 199, penicillin and streptomycin were purchased from Gib-
co BRL, Tween-20 and anti-K smooth muscle actin antibody were
purchased from Sigma, anti-calponin antibody and KM995 were ob-
tained as described previously [19], anti-non-muscle myosin heavy
chain antibody was purchased from Paesel and Lorei (Germany),
Lowry reagents from Bio-Rad. Secondary antibodies, enhanced chem-
iluminescence Western blotting detection reagents and Hyper¢lm-MP
autoradiography ¢lm were purchased from Amersham International,
Amersham, UK. All chemicals used were analytical grade reagents.
3. Results
In order to investigate the expression of contractile proteins
in the presence of oxLDL, SVSC cells and RSMC were used.
SVSC cells possess a unique characteristic ^ their cell growth
is regulated by the cultivation temperature [19] while growth
of RSMC is not. Fig. 1 shows the expression of K-actin, SM1,
calponin and non-muscle myosin in SVSC smooth muscle
cells when exposed to 187 Wg protein/ml of native or oxidized
LDL after a 24 h incubation period. It can be observed that
there is a remarkable decrease in expression of all the smooth
muscle contractile proteins in those samples incubated in the
presence of oxLDL compared to native LDL. More speci¢-
cally, there is a 52% decrease in K-actin expression, a 72%
decrease in SM1 and a 53% decrease in calponin in these
samples. However, non-muscle myosin seems to be una¡ected
by the presence of oxLDL. In Fig. 2, the expression of the
same proteins in RSMC when exposed to 187 Wg protein/ml of
native or oxidized LDL after a 24 h incubation period is
reported. With K-actin there is only an 18% decrease in ex-
pression in samples incubated with oxLDL compared with
native LDL, while with SM1 and with calponin there is a
49% and a 46% decrease, respectively. In this cell line, oxLDL
also seems to mildly a¡ect the expression of non-muscle my-
osin as a 22% decrease in expression is observed.
4. Discussion
During the last few years, active expression of several genes
has been reported in developing atherosclerotic lesions and
oxLDL is one of the factors which contributes to the regula-
tion of gene expression in these lesions [20,21]. In this study,
we provide the ¢rst evidence that the expression of the pro-
teins K-actin, smooth muscle myosin heavy chain-1 and cal-
ponin, involved in smooth muscle cell contraction, is altered
in cultured smooth muscle cells when these are incubated in
the presence of oxidatively modi¢ed LDL. The comparison
between mouse SVSC and RSMC cell cultures o¡ered some
interesting information. Unlike RSMC, SVSC cells seem to
respond to oxLDL to a greater extent since there is an in-
creased downregulation in the expression of the proteins es-
pecially for K-actin. Previous studies have reported a switch in
actin expression in SMC of human atheromatous plaques and
in experimental rat aortic intimal thickening when compared
with SMC of normal media [12]. This switch involves the ratio
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Fig. 1. Comparison of the e¡ects of native and oxidized LDL on
the expression of K-actin, SM1, calponin and non-muscle myosin by
Western blot analysis. SVSC cells were incubated for 24 h in the
presence of either 187 Wg protein/ml native or oxLDL. Data are
representative of experiments in three di¡erent cell cultures.
Fig. 2. Comparison of the e¡ects of native and oxidized LDL on
the expression of K-actin, SM1, calponin and non-muscle myosin by
Western blot analysis. RSMC cells were incubated for 24 h in the
presence of either 187 Wg protein/ml native or oxLDL. Data are
representative of experiments in three di¡erent cell cultures.
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of the di¡erent actin isotypes: from a predominance of the K-
actin isoform in normal media to a predominance of the L
form and a noticeable amount of the Q form in atheromatous
plaque. It has also been reported that myosin heavy chain
isoform expression changed in atherosclerotic human aorta
and experimental atherosclerosis of rabbit carotid artery
[22,23]. Adult rabbit smooth muscle cells contain two types
of myosin heavy chain isoforms, SM1 and SM2, but not non-
muscle myosin heavy chain. Interestingly, non-muscle myosin
heavy chain was re-expressed in proliferating smooth muscle
cells of atherosclerotic neointima. The decrease in K-actin and
SM1 expression observed in this study when SMC were in-
cubated in the presence of oxLDL could possibly be due to
their switch in isoform. Therefore, it would seem from the
results presented here that oxLDL could be one of the factors
responsible for the decrease in K-actin and SM1 expression
observed in human atheromatous plaque. However, not only
does oxLDL seem to exert an in£uence on the expression of
these contractile proteins, it also seems to in£uence the ex-
pression of calponin. The expression of non-muscle myosin
does not seem to be greatly a¡ected by oxLDL if only margin-
ally in RSMC. This investigation of the response of SMC
contractile proteins to oxLDL may provide further insights
into the mechanisms by which oxidatively modi¢ed LDL is
atherogenic. Secondly, it seems conceivable that developments
in the analysis of gene expression in the artery wall at the
cellular level will help in clarifying the sequence of events
which lead to the cellular dysfunction and cytoskeletal alter-
ation that accompany atherosclerotic lesions.
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